Carisma Therapeutics Stock Forward View - Accumulation Distribution
| CARM Stock | 0.04 0 7.14% |
Carisma Stock outlook is based on your current time horizon. Although Carisma Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Carisma Therapeutics' systematic risk associated with finding meaningful patterns of Carisma Therapeutics fundamentals over time.
As of now the rsi of Carisma Therapeutics' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.12) | EPS Estimate Current Year (0.69) | EPS Estimate Next Year (0.52) | Wall Street Target Price 1 | Quarterly Revenue Growth 12.368 |
Using Carisma Therapeutics hype-based prediction, you can estimate the value of Carisma Therapeutics from the perspective of Carisma Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Carisma Relative Strength Index
Carisma Therapeutics Hype to Price Pattern
Investor biases related to Carisma Therapeutics' public news can be used to forecast risks associated with an investment in Carisma. The trend in average sentiment can be used to explain how an investor holding Carisma can time the market purely based on public headlines and social activities around Carisma Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Carisma Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Carisma Therapeutics.
Carisma Therapeutics after-hype prediction price | USD 0.04 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Carisma Therapeutics to cross-verify your projections. Carisma Therapeutics Additional Predictive Modules
Most predictive techniques to examine Carisma price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Carisma using various technical indicators. When you analyze Carisma charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 22275.0 | 0.25 |
| Check Carisma Therapeutics Volatility | Backtest Carisma Therapeutics | Information Ratio |
Carisma Therapeutics Trading Date Momentum
| On February 07 2026 Carisma Therapeutics was traded for 0.04 at the closing time. The top price for the day was 0.05 and the lowest listed price was 0.04 . There was no trading activity during the period 0.0. Lack of trading volume on February 7, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Carisma Therapeutics to competition |
Other Forecasting Options for Carisma Therapeutics
For every potential investor in Carisma, whether a beginner or expert, Carisma Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Carisma Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Carisma. Basic forecasting techniques help filter out the noise by identifying Carisma Therapeutics' price trends.Carisma Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Carisma Therapeutics stock to make a market-neutral strategy. Peer analysis of Carisma Therapeutics could also be used in its relative valuation, which is a method of valuing Carisma Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Carisma Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Carisma Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Carisma Therapeutics shares will generate the highest return on investment. By undertsting and applying Carisma Therapeutics stock market strength indicators, traders can identify Carisma Therapeutics entry and exit signals to maximize returns.
Carisma Therapeutics Risk Indicators
The analysis of Carisma Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Carisma Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting carisma stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.46 | |||
| Standard Deviation | 10.34 | |||
| Variance | 106.84 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Carisma Therapeutics
The number of cover stories for Carisma Therapeutics depends on current market conditions and Carisma Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Carisma Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Carisma Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Carisma Therapeutics Short Properties
Carisma Therapeutics' future price predictability will typically decrease when Carisma Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Carisma Therapeutics often depends not only on the future outlook of the potential Carisma Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Carisma Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 41.5 M | |
| Cash And Short Term Investments | 18.8 M |
Check out Historical Fundamental Analysis of Carisma Therapeutics to cross-verify your projections. To learn how to invest in Carisma Stock, please use our How to Invest in Carisma Therapeutics guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Will Biotechnology sector continue expanding? Could Carisma diversify its offerings? Factors like these will boost the valuation of Carisma Therapeutics. Projected growth potential of Carisma fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Carisma Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 0.19 | Revenue Per Share | Quarterly Revenue Growth 12.368 | Return On Assets | Return On Equity |
Understanding Carisma Therapeutics requires distinguishing between market price and book value, where the latter reflects Carisma's accounting equity. The concept of intrinsic value - what Carisma Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Carisma Therapeutics' price substantially above or below its fundamental value.
It's important to distinguish between Carisma Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Carisma Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Carisma Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.